financetom
Business
financetom
/
Business
/
Jimmy Kimmel defeats George Santos' appeal over videos
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jimmy Kimmel defeats George Santos' appeal over videos
Sep 15, 2025 6:19 PM

*

US appeals court rules in favor of late-night host

*

Kimmel made 'fair use' of ex-congressman's videos

*

Santos serving 7-1/4 prison term for fraud, ID theft

By Jonathan Stempel

NEW YORK, Sept 15 (Reuters) - Jimmy Kimmel defeated an

appeal by former New York Congressman George Santos accusing the

late-night host of tricking him into making personalized videos

on the Cameo app and using them to poke fun at the

now-imprisoned Republican.

In a 3-0 decision on Monday, the 2nd U.S. Circuit Court of

Appeals in Manhattan said Kimmel made "fair use" of the videos

on his ABC show "Jimmy Kimmel Live!" to comment on Santos'

alleged willingness to "say absurd things" for money.

"The complaint paints a portrait of defendants motivated by

(sarcastic) criticism and commentary," not a desire to usurp

Santos' financial interest in the videos, Circuit Judge Raymond

Lohier wrote.

Santos' lawyers did not immediately respond to requests for

comment. A lawyer for Kimmel, ABC and its parent Walt Disney ( DIS )

had no immediate comment.

The defendants were accused of copyright infringement,

fraudulent inducement and other wrongdoing over the videos,

which Kimmel broadcast in segments called "Will Santos Say It?"

Santos has estimated he made more than $350,000 from the

videos, for which he charged about $350 each. He sought

unspecified damages.

Santos was sentenced in April to 7-1/4 years in prison after

pleading guilty to wire fraud and aggravated identity theft

connected to fundraising for his successful 2022 congressional

run.

Santos spent 11 months in office embroiled in scandal,

following revelations he had fabricated much of his resume, and

was expelled from Congress.

He is housed in a medium-security prison in Fairton, New

Jersey, and eligible for release in September 2031.

A trial judge in Manhattan dismissed Santos' civil case against

Kimmel on August 19, 2024, the same day Santos pleaded guilty in

the criminal case in Central Islip, New York.

The case is Santos v Kimmel et al, 2nd U.S. Circuit Court of

Appeals, No. 24-2196.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
--Street Color: Yum! Brands Sues US Internal Revenue Service to Block $4 Billion Tax Bill, Bloomberg Reports
--Street Color: Yum! Brands Sues US Internal Revenue Service to Block $4 Billion Tax Bill, Bloomberg Reports
Jun 5, 2025
11:47 AM EDT, 06/05/2025 (MT Newswires) -- Price: 142.62, Change: -1.38, Percent Change: -0.96 ...
US aluminium premiums hit record levels after tariffs take effect
US aluminium premiums hit record levels after tariffs take effect
Jun 5, 2025
LONDON (Reuters) -Premiums for consumers buying aluminium on the physical market in the United States hit a record 60 cents a lb or $1,323 a metric ton on Thursday after U.S. President Donald Trump imposed higher tariffs on U.S. imports of the metal. The tariffs doubled to 50% on Wednesday. The U.S. Midwest duty-paid premium has gained nearly 190% since...
Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer
Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer
Jun 5, 2025
RegenXBio Inc. ( RGNX ) revealed new interim data on Thursday from the Phase 1/2 AFFINITY DUCHENNE trial. Updates include positive functional, safety, and biomarker data for RGX-202, REGENXBIO’s investigational gene therapy for Duchenne muscular dystrophy. The data update looked at five patients who were six to 12 years old when they received the gene therapy RGX-202. The functional data demonstrate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved